These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 26698583)
1. The Question of Clinical Equipoise and Patients' Best Interests. Hey SP; Truog RD AMA J Ethics; 2015 Dec; 17(12):1108-15. PubMed ID: 26698583 [No Abstract] [Full Text] [Related]
2. Equipoise and the dilemma of randomized clinical trials. Miller FG; Joffe S N Engl J Med; 2011 Feb; 364(5):476-80. PubMed ID: 21288100 [No Abstract] [Full Text] [Related]
4. Equipoise, research stalemates, and the limits of new data. London AJ Am J Bioeth; 2011 Feb; 11(2):10-2. PubMed ID: 21337268 [No Abstract] [Full Text] [Related]
5. On the utility and distinctness of the concept of behavioral equipoise. Blumenthal-Barby JS Am J Bioeth; 2011 Feb; 11(2):9-10. PubMed ID: 21337267 [No Abstract] [Full Text] [Related]
6. Behavior equipoise: is it ready for prime time? Wasson K Am J Bioeth; 2011 Feb; 11(2):14-6. PubMed ID: 21337270 [No Abstract] [Full Text] [Related]
7. Are more trials really the answer? Putting behavioral equipoise in check. Crites J Am J Bioeth; 2011 Feb; 11(2):16-7. PubMed ID: 21337271 [No Abstract] [Full Text] [Related]
8. Science and behavior. Ubel PA; Silbergleit R Am J Bioeth; 2011 Feb; 11(2):W1-2. PubMed ID: 21337265 [No Abstract] [Full Text] [Related]
9. Clinical judgment and deep value commitments. MacDonald C Am J Bioeth; 2011 Feb; 11(2):18-9. PubMed ID: 21337272 [No Abstract] [Full Text] [Related]
10. Behavioral equipoise: a way to resolve ethical stalemates in clinical research. Ubel PA; Silbergleit R Am J Bioeth; 2011 Feb; 11(2):1-8. PubMed ID: 21337264 [TBL] [Abstract][Full Text] [Related]
11. Getting around PLX4032: studies turn up unusual mechanisms of resistance to melanoma drug. Tuma RS J Natl Cancer Inst; 2011 Feb; 103(3):170-1, 177. PubMed ID: 21242335 [No Abstract] [Full Text] [Related]
12. BRIM-1, -2 and -3 trials: improved survival with vemurafenib in metastatic melanoma patients with a BRAF(V600E) mutation. Young K; Minchom A; Larkin J Future Oncol; 2012 May; 8(5):499-507. PubMed ID: 22646765 [TBL] [Abstract][Full Text] [Related]
13. Equipoise and the dilemma of randomized clinical trials. Mann H N Engl J Med; 2011 May; 364(21):2076-7; author reply 2077. PubMed ID: 21612497 [No Abstract] [Full Text] [Related]
14. Equipoise, ethics, and the necessity of randomized trials in surgery. Adibe OO; St Peter SD Arch Surg; 2012 Oct; 147(10):899-900. PubMed ID: 23070406 [No Abstract] [Full Text] [Related]
15. The natural history of malignancies under conditions of BRAF inhibitor stimulation. White RM Expert Opin Investig Drugs; 2011 Jan; 20(1):135-6. PubMed ID: 21117980 [No Abstract] [Full Text] [Related]
16. A critique of clinical equipoise. Therapeutic misconception in the ethics of clinical trials. Miller FG; Brody H Hastings Cent Rep; 2003; 33(3):19-28. PubMed ID: 12854452 [TBL] [Abstract][Full Text] [Related]
17. Randomized controlled trials of maternal-fetal surgery: a challenge to clinical equipoise. Rodrigues HC; van den Berg PP Bioethics; 2014 Oct; 28(8):405-13. PubMed ID: 23025329 [TBL] [Abstract][Full Text] [Related]
18. Vemurafenib for the treatment of BRAF mutant metastatic melanoma. Martin-Liberal J; Larkin J Future Oncol; 2015; 11(4):579-89. PubMed ID: 25686114 [TBL] [Abstract][Full Text] [Related]